» Articles » PMID: 30237473

Dystonia

Overview
Specialty General Medicine
Date 2018 Sep 22
PMID 30237473
Citations 135
Authors
Affiliations
Soon will be listed here.
Abstract

Dystonia is a neurological condition characterized by abnormal involuntary movements or postures owing to sustained or intermittent muscle contractions. Dystonia can be the manifesting neurological sign of many disorders, either in isolation (isolated dystonia) or with additional signs (combined dystonia). The main focus of this Primer is forms of isolated dystonia of idiopathic or genetic aetiology. These disorders differ in manifestations and severity but can affect all age groups and lead to substantial disability and impaired quality of life. The discovery of genes underlying the mendelian forms of isolated or combined dystonia has led to a better understanding of its pathophysiology. In some of the most common genetic dystonias, such as those caused by TOR1A, THAP1, GCH1 and KMT2B mutations, and idiopathic dystonia, these mechanisms include abnormalities in transcriptional regulation, striatal dopaminergic signalling and synaptic plasticity and a loss of inhibition at neuronal circuits. The diagnosis of dystonia is largely based on clinical signs, and the diagnosis and aetiological definition of this disorder remain a challenge. Effective symptomatic treatments with pharmacological therapy (anticholinergics), intramuscular botulinum toxin injection and deep brain stimulation are available; however, future research will hopefully lead to reliable biomarkers, better treatments and cure of this disorder.

Citing Articles

Assessment of quality of life in patients with cervical dystonia and hemifacial spasm after botulinum toxin injections.

Elshebawy H, Ramzy G, Salama M, El-Jaafary S Acta Neurol Belg. 2025; .

PMID: 39992580 DOI: 10.1007/s13760-025-02742-x.


Sweet spot for resting-state functional MRI effect of deep brain stimulation in dystonia lies in the lower pallidal area.

Filip P, Lasica A, Kiakou D, Mueller K, Keller J, Urgosik D Neuroimage Clin. 2025; 45:103750.

PMID: 39986202 PMC: 11889665. DOI: 10.1016/j.nicl.2025.103750.


The DYT6 dystonia causative protein THAP1 is responsible for proteasome activity via PSMB5 transcriptional regulation.

Wang Y, Wang Y, Iriki T, Hashimoto E, Inami M, Hashimoto S Nat Commun. 2025; 16(1):1600.

PMID: 39952963 PMC: 11828994. DOI: 10.1038/s41467-025-56867-x.


The epidemiology and phenomenology of non-antipsychotic-induced dystonia: a hybrid systematic-narrative review.

Kirsten C, Catthoor K, Detraux J, Johan D, De Hert M Eur Psychiatry. 2025; 68(1):e36.

PMID: 39925222 PMC: 11883798. DOI: 10.1192/j.eurpsy.2025.18.


Second-generation antipsychotic-induced dystonia: Analysis using the Japanese Adverse Drug Event Report (JADER) database.

Ebina T, Iwamoto K, Ando M, Ikeda M Psychiatry Clin Neurosci. 2025; 79(3):117-124.

PMID: 39834274 PMC: 11874247. DOI: 10.1111/pcn.13785.


References
1.
Augustine P, Danforth H . A study of the dynamics of the invasion of immunized birds by Eimeria sporozoites. Avian Dis. 1986; 30(2):347-51. View

2.
Blackaller J . Design affords openness--both inside and out. Dent Surv. 1975; 51(8):80-1. View

3.
KUREBE M, Asaoka H, Moriguchi M, Hata T, Okano K, Ito M . [A study of the effect of (2"R)-4'-O-tetrahydropyranyladriamycin, a new antitumor antibiotic, on reproduction. II. Its teratogenicity in rats and rabbits]. Jpn J Antibiot. 1986; 39(2):477-506. View

4.
Jacobs P, le Roux I, King H . Sequential half-body irradiation as salvage therapy in chemotherapy-resistant multiple myeloma. Am J Clin Oncol. 1988; 11(2):104-9. DOI: 10.1097/00000421-198804000-00003. View

5.
Kinnunen E, Koskenvuo M, Kaprio J, Aho K . Multiple sclerosis in a nationwide series of twins. Neurology. 1987; 37(10):1627-9. DOI: 10.1212/wnl.37.10.1627. View